1 |
World Health Organization: Ageing and Health Technical Report Vol. 5: A Glossary of Terms for Community Health Care and Services for Older Persons. In.; 2004.
|
2 |
Mortazavi SS, Shati M, Keshtkar A, et al. Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open 2016;6(3):e010989.
DOI
|
3 |
Herr M, Robine JM, Pinot J, et al. Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf 2015;24(6):637-46.
DOI
|
4 |
Jyrkka J, Enlund H, Lavikainen P, et al. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf 2011;20(5):514-22.
DOI
|
5 |
Nobili A, Pasina L, Tettamanti M, et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther 2009; 34(4):377-86.
DOI
|
6 |
Wang R, Chen L, Fan L, et al. Incidence and Effects of Polypharmacy on Clinical Outcome among Patients Aged 80+: A Five-Year Follow-Up Study. PLoS One 2015; 10(11):e0142123.
DOI
|
7 |
Fried TR, O'Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc 2014; 62(12):2261-72.
DOI
|
8 |
Park HY, Park JW, Song HJ, et al. The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea. PLoS One 2017;12(1):e0169463.
DOI
|
9 |
Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr 2017; 17(1):230.
|
10 |
Park HY, Park JW, Sohn HS, et al. Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case-Control Study in South Korea. Drug Saf 2017.
|
11 |
Kim HA, Shin JY, Kim MH, et al. Prevalence and predictors of polypharmacy among Korean elderly. PLoS One 2014; 9(6):e98043.
DOI
|
12 |
Nam YS, Han JS, Kim JY, et al. Prescription of potentially inappropriate medication in Korean older adults based on 2012 Beers Criteria: a cross-sectional population based study. BMC Geriatr 2016; 16:118.
DOI
|
13 |
Park HY, Ryu HN, Shim MK, et al. Prescribed drugs and polypharmacy in healthcare service users in South Korea: an analysis based on National Health Insurance Claims data. Int J Clin Pharmacol Ther 2016; 54(5):369-77.
DOI
|
14 |
McCracken R, McCormack J, McGregor MJ, et al. Associations between polypharmacy and treatment intensity for hypertension and diabetes: a cross-sectional study of nursing home patients in British Columbia, Canada. BMJ Open 2017; 7(8):e017430.
|
15 |
Sinnige J, Braspenning JC, Schellevis FG, et al. Inter-practice variation in polypharmacy prevalence amongst older patients in primary care. Pharmacoepidemiol Drug Saf 2016;25(9):1033-41.
DOI
|
16 |
Saum KU, Schottker B, Meid AD, et al. Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study. J Am Geriatr Soc 2017; 65(2):e27-e32.
DOI
|
17 |
Moriarty F, Hardy C, Bennett K, et al. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open 2015; 5(9):e008656.
DOI
|
18 |
Beer C, Hyde Z, Almeida OP, et al. Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study. Br J Clin Pharmacol 2011; 71(4):592-9.
DOI
|
19 |
Franchi C, Cartabia M, Risso P, et al. Geographical differences in the prevalence of chronic polypharmacy in older people: eleven years of the EPIFARM-Elderly Project. Eur J Clin Pharmacol 2013;69(7):1477-83.
DOI
|
20 |
Niikawa H, Okamura T, Ito K, et al. Association between polypharmacy and cognitive impairment in an elderly Japanese population residing in an urban community. Geriatr Gerontol Int 2017;17(9):1286-93.
DOI
|
21 |
Nishtala PS, Salahudeen MS. Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005-2013. Gerontology 2015;61(3):195-202.
DOI
|
22 |
Lu WH, Wen YW, Chen LK, et al. Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. CMAJ 2015;187(4):E130-7.
DOI
|
23 |
Charlesworth CJ, Smit E, Lee DS, et al. Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988-2010. J Gerontol A Biol Sci Med Sci 2015;70(8):989-95.
DOI
|
24 |
Richardson K, Ananou A, Lafortune L, et al. Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging 2011;28(7):547-60.
DOI
|
25 |
Jang IY, Lee YS, Jeon MK, et al. Potentially Inappropriate Medications in Elderly Outpatients by the 2012 Version of Beers Criteria: A Single Tertiary Medical Center Experience in South Korea. J Korean Geriatr Soc 2013;17:126-33.
DOI
|
26 |
Kojima T, Akishita M, Nakamura T, et al. Polypharmacy as a risk for fall occurrence in geriatric outpatients. Geriatr Gerontol Int 2012;12(3):425-30.
DOI
|
27 |
Zia A, Kamaruzzaman SB, Tan MP. The consumption of two or more fall risk-increasing drugs rather than polypharmacy is associated with falls. Geriatr Gerontol Int 2017;17(3):463-70.
DOI
|
28 |
Thorell K, Ranstad K, Midlov P, et al. Is use of fall risk-increasing drugs in an elderly population associated with an increased risk of hip fracture, after adjustment for multimorbidity level: a cohort study. BMC Geriatr 2014;14:131.
DOI
|
29 |
Laflamme L, Monarrez-Espino J, Johnell K, et al. Type, number or both? A population-based matched case-control study on the risk of fall injuries among older people and number of medications beyond fallinducing drugs. PLoS One 2015;10(3):e0123390.
|
30 |
Lai SW, Lin CH, Liao KF, et al. Association between polypharmacy and dementia in older people: a population-based case-control study in Taiwan. Geriatr Gerontol Int 2012;12(3):491-8.
DOI
|
31 |
Aronson JK. In defence of polypharmacy. Br J Clin Pharmacol 2004; 57(2):119-20.
DOI
|
32 |
Aronson JK. Polypharmacy, appropriate and inappropriate. Br J Gen Pract 2006;56(528):484-45.
|
33 |
Cole A, Wright H: The importance of 'appropriate' polypharmacy and the value of medicines. European Journal of Hospital Pharmacy 2017; 24(1):70-2.
|
34 |
Kuijpers MA, van Marum RJ, Egberts AC, et al. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008; 65(1):130-3.
DOI
|
35 |
Patterson SM, Cadogan CA, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2014;10:CD008165.
|
36 |
Oboh L, Qadir MS. Deprescribing and managing polypharmacy in frail older people: a patient-centred approach in the real world. European Journal of Hospital Pharmacy 2017;24(1):58-62.
DOI
|
37 |
Cullinan S, Raae Hansen C, Byrne S, et al. Challenges of deprescribing in the multimorbid patient. European Journal of Hospital Pharmacy 2017; 24(1):43-6.
DOI
|
38 |
Levy HB. Polypharmacy Reduction Strategies: Tips on Incorporating American Geriatrics Society Beers and Screening Tool of Older People's Prescriptions Criteria. Clin Geriatr Med 2017;33(2):177-187.
DOI
|
39 |
Barnett N, Jubraj B. A themed journal issue on deprescribing. European Journal of Hospital Pharmacy 2017;24(1):1-2.
DOI
|
40 |
Scott I, Anderson K, Freeman C. Review of structured guides for deprescribing. European Journal of Hospital Pharmacy 2017;24(1):51-7.
DOI
|
41 |
Bulajeva A, Labberton L, Leikola S, et al. Medication review practices in European countries. Res Social Adm Pharm 2014;10(5):731-40.
DOI
|
42 |
Kwon KH. A study on the pharmacy manpower project "Vision 2013"; A research report for the Ministry of Health and Welfare. In.; 2013.
|
43 |
Dhillon AK, Hattingh HL, Stafford A, et al. General practitioners' perceptions on home medicines reviews: a qualitative analysis. BMC Fam Pract 2015;16:16.
DOI
|
44 |
Mair A, Fernandez-Llimos F. Polypharmacy management programmes: the SIMPATHY Project. European Journal of Hospital Pharmacy 2017;24(1):5-6.
DOI
|
45 |
Australian Government Department of Health. Medication management reviews. Online at. Available from http://www.health.gov.au/internet/main/publishing.nsf/Content/medication_management_reviews.htm. Accessed September 28 2017.
|
46 |
Chen TF. Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian Model. Drugs Aging 2016;33(3):199-204.
DOI
|
47 |
Gilbert AL, Roughead EE, Beilby J, et al. Collaborative medication management services: improving patient care. Med J Aust 2002; 177(4):189-92.
|
48 |
Emblen G, Miller E. Home medicines review. The how and why for GPs. Aust Fam Physician 2004;33(1-2):49-51.
|
49 |
Dolovich L, Consiglio G, MacKeigan L, et al. Uptake of the MedsCheck annual medication review service in Ontario community pharmacies between 2007 and 2013. Canadian Pharmacists Journal 2016;149(5):293-302.
|
50 |
Barnett MJ, Frank J, Wehring H, et al. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm 2009;15(1):18-31.
|
51 |
Matlin OS, Kymes SM, Averbukh A, et al. Community pharmacy automatic refill program improves adherence to maintenance therapy and reduces wasted medication. Am J Manag Care 2015;21(11):785-91.
|
52 |
The Ministry of Health and Welfare. Drug Utilization Review; DUR system. Available from http://www.mohw.go.kr/front_new/policy/index.jsp?PAR_MENU_ID=06&MENU_ID=062904&PAGE=4. Accessed November 11, 2017.
|